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Abstract
Introduction and hypothesis This qualitative interview study explores aspects womenwith urinary incontinence(UI) reflect upon
when considering whether or not to have surgery. Conducted prior to the recent mesh pause in the UK, the article provides
insights for current and future approaches to shared decision-making.
Methods Qualitative in-depth interviews of 28 patients referred to secondary care for stress and mixed UI who were considering
UI surgery. Participants were recruited from four urogynaecology clinics in the Midlands and South England, UK. Interviews
were conducted in clinics, in patient homes, and by telephone. Data analysis was based on the constant comparative method.
Results Participants’ accounts comprised three key concerns: their experience of symptoms, the extent to which these impacted a
variety of social roles and demands, and overcoming embarrassment. Accounts drew on individual circumstances, values, and
concerns rather than objective or measurable criteria. In combination, these dimensions constituted a personal assessment of the
severity of their UI and hence framed the extent to which women prioritized addressing their condition.
Conclusions Acknowledging women’s personal accounts of UI shifts the concept of ‘severity’ beyond a medical definition to
include what is important to patients themselves. Decision-making around elective surgery must endeavour to link medical
information with women’s own experiences and personal criteria, which often change in priority over time. We propose that this
research provides insight into how the controversy around the use of mesh in the UK emerged. This study also suggests ways in
which facilitating shared decision-making should be conducted in future.
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Introduction
The recent controversy in the UK over the use of surgical
mesh to treat female urinary incontinence (UI) has led the
National Institute for Healthcare Excellence (NICE)—the
body dedicated to inform the National Health Service over
appropriate, and affordable, treatment options—to produce a
decision tool for women considering the procedure. This aid
comprises plain English summaries of the latest clinical evi-
dence concerning possible complications to help women re-
flect and order their priorities around symptom control and
possible risks [1].
This patient decision aid, and others like it, can clearly play
a vital role [2]. However, women’s decisions are not neces-
sarily based solely on their appreciation of clinical evidence or
assessing the physical risks an intervention might have for
them individually. Rather than conceiving patient decisions
as being based solely on medical understandings, and a quest
for certainty, this article draws on qualitative data to examine
what other factors women draw on when faced with decisions
around UI surgery.
The promotion of shared decision-making has long been
established as good practice within the NHS and beyond [3].
* Rebecca Lynch
rebecca.lynch@kcl.ac.uk
1 Department of Health Services Research and Policy, Faculty of
Public Health and Policy, London School of Hygiene & Tropical
Medicine, London, UK
2 School of Population Health and Environmental Sciences, Faculty of
Life Sciences and Medicine, King’s College London, Addison
House, Guy’s Campus, Great Maze Pond, London WC1H 9SH, UK
3 Birmingham Women’s and Children’s NHS Foundation Trust,
Birmingham, UK
4 Medway NHS Foundation Trust, Gillingham, Kent, UK
5 Department of Health Sciences, College of Life Sciences, University
of Leicester, Leicester, UK
https://doi.org/10.1007/s00192-020-04383-5
/ Published online: 29 June 2020
International Urogynecology Journal (2021) 32:127–133
While urgent or emergency treatments rarely constitute occa-
sions for patients to be actively involved in decisions, long-
term treatments and elective surgery both present opportuni-
ties for them to deliberate their options [4, 5]. Much has been
written about how and when patients might be able to truly
participate [6–9]. However, there has also been critique [10],
especially concerning the undeniable differences in expertise
and authority between clinicians and patients [11]. It is there-
fore pertinent to question whether providing just clinical evi-
dence is ever an adequate strategy to ensure patients genuinely
engage in a decision-making process. This is a particularly
important consideration in relation to a stigmatized condition
such as UI, which has multiple cultural values, meanings, and
associations.
To address these, we present a qualitative study that was
conducted prior to the national pause on the use of mesh for
pelvic floor reconstruction and the publication of the NICE
decision aid. The timing of data collection means that we are
able to highlight other factors which are just as pertinent to
women when considering whether to have surgery or not, but
which tend to be omitted in the traditional decision-making
paradigm. Specifically, medical consultations base decision-
making discussions on clinical measures of UI severity, name-
ly the frequency and quantity of urine leakage [12]. However,
this may not be the most meaningful or relevant criteria for
women themselves. This article presents the ways women
themselves judge the severity of their condition, its priority
in their lives, and the criteria they draw on to make decisions
about surgery.
Materials and methods
Semi-structured interviews were undertaken with women con-
sidering surgery for their UI. Participants were recruited from
four urogynaecology outpatient clinics in different parts of
England: Birmingham, Gillingham (Kent), Leicester, and
Southampton, between May–December 2017. Female pa-
tients referred to these clinics with stress or mixed inconti-
nence who met the study criteria (considering UI surgery, >
18 years old, no history of urology surgery) were approached
by members of the clinic teams (including JD, DT, PTH and
physiotherapists, nurses, surgical consultants, and specialist
registrars) as part of routine appointments. Those potentially
interested in participating were given an information sheet and
form to complete and return directly to the social science re-
search team at LSHTM (RL and SC). Members of clinical
teams were not informed which patients had returned forms.
Interviewees were then purposively sampled by region and
age to ensure a diverse, rather than statistically relevant,
sample.
Interviews covered women’s experiences of UI, actions
they took to accommodate the condition, and their
expectations of future surgical/non-surgical interventions.
Interviewswere conducted face to face or by phone, according
to patient preference. Written consent was always obtained
after participants were given the opportunity to ask clarifying
questions. Interviews were based on a general topic guide,
lasted between 40 and 130 min, and were audio-recorded.
Transcription was undertaken verbatim by an external compa-
ny accustomed to dealing with confidential data. Publicity
relating to the mesh controversy grew in England and Wales
during the study, but interviews were completed several
months before this specific intervention was put on ‘pause’
while further evidence was called for [13].
Transcripts were anonymized and coded using the qualita-
tive data management systemNVivo 10. Following a constant
comparative method [14, 15], emerging themes were followed
up in greater depth during subsequent interviews, such that the
topic guide became focused on subjects that were most impor-
tant to participants themselves. Initial coding was undertaken
by RL while recruitment and interviews were underway. The
codes, drawn both deductively from the interview topic guide
and inductively through early analysis, were augmented and
refined during analysis. SC oversaw the process and blind-
coded a sample to ensure reliability. Codes were arranged into
hierarchies, with those deemed to be too similar collapsed
together; the resulting structure was discussed with JD, DT,
and PTH who helped further refine the analysis.
The study was funded by the UKNational Institute for Health
Research (NIHR) Health Services and Delivery Research
(HS&DR) Programme (14/70/162). Patient representatives from
the UK’s Royal College of Obstetricians and Gynaecologists
(RCOG)Women’s Voices network (an online panel of members
of the public who have experiences of using women’s health
services) were consulted when designing the study and applying
for funding and remained involved as members of the project’s
advisory board. They informed the design of the interview topic
guide and data analysis through discussion and feedback of early
findings and conclusions drawn.
Results
Twenty-eight female patients were interviewed from across
the four sites. The overall age range was 26–74 years (see
Table 1). Fourteen requested to be interviewed in their homes,
11 in clinics, and 3 by telephone. There were no significant
differences across the four sites, despite predictions that they
were drawn from distinct populations. Most participants had
had UI for an extended period of time; in some cases, for >
20 years. For all the women, surgery was clinically indicated
and an immanent possibility.
Speaking to patients who were actively thinking about sur-
gical options allowed exploration of those factors women
themselves considered and raised as important, which were
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often related to their personal experiences of UI and how they
had lived with it up until this point. Rather than being led by a
decision tool that forefronted clinical evidence, this approach
alerted us to broader values and understandings women had
and how these connected to their everyday lives. Women’s
considerations centered on three key concerns: perceptions of
how serious the physical symptoms of the condition was; how
to prioritize their condition and its treatment over a wide range
of responsibilities that they had in their daily life; and the need
to overcome embarrassment and shame as their condition be-
came more visible through seeking further treatment.
‘How bad is my condition?’
Rather than adopting an abstract clinical measure of severity,
women often tried to assess their condition by comparing
themselves to other women with similar symptoms or of sim-
ilar age. In this way they attempted to establish what a ‘nor-
mal’ amount and frequency of urine loss might be;
‘I’ve had the same peer group since I was a young girl,
and my friends will go out and they don’t have to take
spare knickers in their bag in case they laugh on the
dancefloor or they trip over, or a sudden movement
happens that they have an issue with incontinence.
(Interviewee 11, 38 years old)
Such comparisons were then linked to the possible treat-
ment routes they were considering;
‘…my problem doesn’t feel bad enough to go for sur-
gery…I really wanted to keep going with the physio and
try and sort it out that way … (Interviewee 7, 51 years
old)
Trying to establish if their UI was particularly bad some-
times also included reflections on the likely burden of certain
interventions on NHS resources. This led women to question
whether their current symptoms were sufficiently severe to
warrant financial justification, especially when they might just
be part of ageing;
‘… do I take any action around this, is this a normal part
of ageing, do I accept it, do other people accept it, is the
problem I’ve got worse, or not as bad as other people?
You don’t know how to compare yourself with other
people because it’s not really talked about… I men-
tioned it to two people and they’ve both said, well they
implied, that it’s something you just accept with age.’
(Interviewee 6, 66 years old)
However, a common catalyst to consider surgery for the
women in this study was not how ‘bad’ their symptoms were
in some objective way, but, instead, how much ‘worse’ they
had become over time. As their personal circumstances
changed, many reported how their symptoms became more
obvious and unmanageable;
‘I feel like it’s got worse, I feel like my bladder has got
weaker, that I haven’t been able to retain it as much…’
(Interviewee 26, 32 years old)
The changing nature of the symptoms, and the feeling that
they could no longer be successfully managed, shaped the
way in which the option to have surgery gained likelihood.
But while some described having surgery in terms of an in-
vestment in their future, this was often hard for many inter-
viewees to establish definitively;
‘I don’t really want it [the operation]. But if I delay it,
I’m getting older, whereas obviously, 40, almost 41, my
youngest is 13, my oldest is 17, so at some point they’re
going to leave. I might as well enjoy the time now, and
be able to do more.’ (Interviewee 23, 40 years old)
Overall, judging how bad their condition was as a basis of
whether to have surgery was always a complex and personal
process. Rather than striving to establish a consistent indepen-
dent measure, women tended to adopt a comparative approach
to their evaluations—whether in relation to other women that
they spoke to or read about, their assumptions about what an
ageing woman’s body might be like, or by comparing their
current symptoms with personal recollections concerning how
their UI symptoms had been in the past. This more subjective,
relational strategy reflects the fact that the women invariably
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talked about their condition using specific real-life experi-
ences and detailed first-hand accounts rather than a detached
and depersonalized medical assessment of their UI.
Competing demands
In addition to trying to describe the seriousness of their con-
dition in terms of other women or the progression of symp-
toms, participants invariably described management of UI and
the possibility of surgery in relation to competing demands
with their role as mothers, daughters, partners, siblings,
friends, and employees;
‘It doesn’t just affect me because it affects my partner as
well because when we go out…if we're out for an hour
then we have to come back. So, it affects him, you
know…or if I go out with friends, or whatever, I end
up having to come home.’ (Interviewee 28, 47 years old)
These social roles were clearly central not only to how the
women thought about themselves, but crucially also judged
the relative significance of their UI and importance of their
treatment. One participant, for example, talked about having
to cancel one of her diagnostic tests as she had to attend to her
daughter that day, while another prioritized caring for her
8 year old leading her to opt for injections rather than the more
invasive and time-demanding surgery.
All the women described strategies they had adopted not to
let their UI disrupt these roles as far as possible; for example,
by always carrying (and hiding) incontinence pads with them;
by having changes of clothes at hand, or wearing dark trousers
to hide any accidents; or avoiding particular activities, such as
going running or playing with their children or grandchildren;
‘The most difficult and tough thing about it, was that
when you want to go and do something, it’s like, come
on the bouncy castle, or come and do this or do that, you
sort of think, no I can’t do it… ‘cause I was leaking’
(Interviewee 20, 51 years old).
Core to all these everyday tactics was the attempt to accom-
modate and hide their UI, frequently conveying a tension be-
tween their commitment to different forms of work and care they
did for others and the personal impact of their UI symptoms.
Women whose symptoms were very pronounced and impacted
their lives in a dramatic way found it easier to consider a surgical
option. For others, it was the fact that these kinds of demands had
reduced over the years which meant that they were now consid-
ering surgery; for example, one patient in her 60s said that now
that her husband’s ill health had got better, she could finally
attend to her own condition. It is also worth noting that for some
women, UI was not their only health condition and dealing with
other health issues sometimes competed with it or were more
urgent to resolve through treatment.
Although a minority of interviewees talked about feeling
too embarrassed to share their situation with anyone they
knew, others discussed their situation with partners, friends,
colleagues, and sometimes parents or daughters, in addition to
with clinical staff. These informal conversations helped them
reflect on the impact of their UI on their everyday lives, the
extent to which it should potentially take precedence, and
hence whether to decide to have surgery. Key to these more
casual social interactions was that, rather than trying to gain
greater medical understanding, they tended to include the
emotional and personal dimensions of having UI and what
they hoped surgery might change.
Impact of embarrassment and shame
Embarrassment and shame were key elements of most women’s
accounts of living with UI, but crucially these feelings had wider
reverberations in relation to the decision about treatment options.
Many participants said that although they had tried to find out
about other women’s personal experiences, the stigmatized na-
ture of the condition meant that intimate details were not often
discussed or shared openly. As a result, the women described
how they had to glean information indirectly; they described how
they would ‘listen out’ for relevant comments from the casual
conversations of different people they encountered as well as
learning things in an ad hoc fashion from newspapers, magazine
articles, and websites that they stumbled across.
While women described how, in the past, they had put
much time and effort into hiding their condition effectively,
seeking further treatment required making their UI more vis-
ible. Participants explained the difficulty they had in overcom-
ing their feelings and finding the right words and appropriate
way to talk about their experiences to clinical staff. Although
the gender of the staff member was significant to some, who
invariably preferred speaking to women, more generally it
was the manner of the clinician and the fact that the problem
was taken seriously that emerged as more significant. Follow-
up appointments were often easier to have than the initial time
these concerns had to be dealt with;
‘I think I was probably more comfortable going back
again, because I’d been there before, I remembered
him, he was a lovely doctor, and I guess the intrusion
had already been done, I’d already opened up, you know
what it’s like, the first times you speak about some
things are harder’ (Interviewee 21, 46 years old)
However, not only were women having to disclose the state
of their symptoms to health professionals, but they often also
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had to describe their UI, at a new level of detail, to significant
others. Having to have tests, go to appointments, and perhaps
ultimately have surgery inevitablymeant they had to talkmore
openly to spouses, family, friends, or employers to work out
arrangements for their current roles, responsibilities, and work
commitments. But this meant that their UI inescapably would
become more public.
As for clinical staff, female friends, family members, and
work associates were viewed as easier to speak to than male
acquaintances;
‘My husband, I did tell him a bit, but you don’t need to
tell him toomuch, he’s a man. Yes, I won’t go into depth
with him… Obviously, my friends don’t need to know,
and the children, I will [tell] them at some point. The
boys, I won’t tell as much as my daughter, she would
have a bit more information, because the boys won’t be
bothered’ (Interviewee 23, 40 years old)
Finally, the possibility of a surgical intervention further
exacerbated these concerns over shame and embarrassment
for many, with many expressing a fear that the procedures
inevitably would mean that an intimate part of their anatomy
would have to be exposed;
‘I didn’t think they would actually be doing it through
the vagina. So, obviously anything to do with your pri-
vate area you’re going to be a bit nervous about. It’s
something completely different that, the only person
that’s ever been there is when I’ve had children.’
(Interviewee 10, 26 years old)
Overall, these personal feelings of shame and embarrass-
ment presented an initial obstacle that participants had to over-
come to seek help once they felt their UI symptoms had be-
come intolerable: What had often been very private and secret
for many years had to be made more public and visible.
However, these feelings also remained an ongoing aspect that
shaped how women engaged with any future treatment
choices and the kinds of interactions that would inevitably
be part of the process. In this way, the very emotive dimen-
sions of UI were not simply a secondary response to the con-
dition, but had a direct effect on the options considered and the
consequences future interventions would have on a wide va-
riety of their social relationships.
Discussion
Although it may be assumed that the greater the clinical eval-
uation of UI severity the more essential women would regard
having surgery, this study suggests this is often not a straight-
forward relationship; many more values, understandings, and
experiences are brought into consideration. While medical
decisions about the suitability of patients for UI surgery fre-
quently assess severity through the quantity and frequency of
leakage, women judge the severity of their UI using a much
broader set of criteria, ranging from personal bodily experi-
ences to how extensively the condition disrupts their social
roles and everyday routines. As part of this process, women
routinely draw on the ideas, opinions, and experiences of
others. As such, if the concept of ‘severity’ is to be drawn
on as part of a shared decision-making process, it must move
beyond a medical assessment of UI to include what is impor-
tant to women themselves. Based on our findings, two differ-
ent women with the same level of frequency and amount of
unintentional urine loss can experience their UI very differ-
ently. Severity is consequently always contingent, and identi-
cal interventions are not the same or desired solution for dif-
ferent patients, even if clinically indicated as being so.
There is no doubt that decision aids can be very useful and
help patients understand and appreciate complex and often
competing clinical factors [2]. However, our study makes it
clear how women do not evaluate surgical options ‘in the
abstract’, according to epidemiological ideas of risk or so-
called objective measures. Instead, they draw on particular,
everyday experiences to weigh up factors and guide them.
The result is not only that thinking about options routinely
draws on a diverse set of other people and elements, but also
that it can respond to changing values and priorities, as differ-
ent experiences, hopes, and expectations become
foregrounded. Decisions are therefore rarelymade conclusive-
ly; some degree of hesitancy, uncertainty, and indeterminacy
is always present. By broadening our understanding of the
range of relevant values that women draw on, we argue that
decision-making around surgery is not only a distributed pro-
cess based on multiple criteria, but that factors often take on
greater importance than others at different times.
Additionally, while medical accounts often depict deci-
sions as singular events based on rational, knowledge-driven
processes, our findings demonstrate how, in practice, many
decisions are actually established over multiple meetings with
different people and encounters [16, 17]. Many of these en-
counters are shaped by emotional aspects of the condition, as
much as simply discussing options and exchanging knowl-
edge. In particular, the need to shift from strategies of secrecy
to having to be more open and public about their UI not only
meant women frequently hesitated, but also re-evaluated
whether their symptoms really were so intolerable after all.
In combination, we suggest that these findings potentially
offer insight into how the controversy over the use of mesh
took off in the UK. Rather than simply arising from competing
claims over medical evidence, doubts about the procedure
gained veracity through media representations of women’s
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first-hand accounts [18]. These had a level of influence pre-
cisely because they served as a vehicle to amplify many of
existing emotional and experiential dimensions that we de-
scribe in this article.
A limitation of the study is that in only recruiting pa-
tients who had been referred to secondary care and were
considering surgery, we were unable to capture those
women whose experiences of UI and thoughts around
surgery meant that they remained within primary care or
were not using NHS services at all. Furthermore, women
who did not wish, or felt unable, to be interviewed may
share characteristics that were not captured, especially as
the study was unable to sample according to ethnicity.
Investigating the experiences of women who had had suc-
cessive urogynaecology surgeries was beyond the realm
of this study but it is likely that previous surgeries for
similar symptoms may produce a different range of re-
sponses than those considering this kind of intervention
for the first time. While age differences are evident in the
responses given by the women we interviewed, a greater
number of interviews may well have revealed further seg-
mentation of the participant cohort, potentially highlight-
ing differences both due to biological age or because they
were brought up and socialized during very different eras.
Despite such limitations, our study suggests that in
considering patient concerns around the use of mesh in
surgery, clinical staff should not overly focus on factual
inaccuracies that patients may have, but look to under-
stand the wider context of patients’ lives to recognize that
this is often just as active a domain of considerations in
their decision-making process. Indeed, promoting clinical
evidence as a response to the controversy without doing
so has the potential to further disenfranchise many pa-
tients who seek a wider sense of meaningful dialogue
and support. We therefore suggest that any future iteration
of a patient decision-aid, such as that produced by NICE,
should integrate the non-clinical aspects we describe in
addition to current clinical evidence, since these social
and emotional factors will always remain central to how
medical information is interpreted and contextualized by
women.
These considerations also have important consequences for
thinking about personalizing clinical approaches to decision-
making more generally and potentially provide insight into
mechanisms by which some medical controversies and con-
spiracies take hold. Acknowledging the fact that patients rare-
ly, if ever, base their assessments solely on clinical symptoms,
their understanding of medical evidence, and the likelihood of
a successful intervention according to current scientific evi-
dence demands approaches that genuinely take into account
their own points of view and the relationships between a con-
dition and their wider social networks, circumstances, roles,
and situations.
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